← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 15, 2016Last known activity
Feb 12, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 7 trials)
Phase 2 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (12)
- NCT07271121Lead sponsorPhase 2Feb 12, 2025
- NCT06689358Lead sponsorN/ANov 1, 2022
- NCT05113810CollaboratorPhase 2Dec 4, 2021
- NCT04731051Reponsible party - principal investigatorPhase 1/Phase 2Jul 31, 2021
- NCT04731051Lead sponsorPhase 1/Phase 2Jul 31, 2021
- NCT04731051Overall official - principal investigatorPhase 1/Phase 2Jul 31, 2021
- NCT04374903Lead sponsorN/AMay 1, 2020
- NCT04354597Reponsible party - principal investigatorN/AMay 1, 2020
- NCT04374903Reponsible party - principal investigatorN/AMay 1, 2020
- NCT04354597Lead sponsorN/AMay 1, 2020
- NCT04246021Reponsible party - principal investigatorN/AJun 15, 2016
- NCT04246021Lead sponsorN/AJun 15, 2016
Details
- Last known activity
- Feb 12, 2025